Inactive Instrument

Company Laboratorio Reig Jofre SA CINNOBER BOAT

Equities

0RB1

ES0165359029

Pharmaceuticals

Business Summary

Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.

Sales per Business

EUR in Million2022Weight2023Weight Delta
Pharmaceutical Services
81.0 %
217 80.0 % 256 81.0 % +18.06%
Nutritional Supplements
19.0 %
54 20.0 % 60 19.0 % +10.62%

Sales per region

EUR in Million2022Weight2023Weight Delta
Spain
44.6 %
119 43.7 % 141 44.6 % +18.98%
European Union
36.5 %
110 40.7 % 115 36.5 % +4.56%
Asia
8.1 %
16 5.8 % 26 8.1 % +62.90%
Rest of Europe
7.0 %
17 6.2 % 22 7.0 % +33.15%
Africa
1.6 %
4 1.6 % 5 1.6 % +18.44%
Americas
1.3 %
3 1.2 % 4 1.3 % +26.07%
Oceania
0.7 %
2 0.7 % 2 0.7 % +15.34%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 31/12/05
Chief Tech/Sci/R&D Officer - 31/12/02
Chief Operating Officer 52 31/12/02
- -
Investor Relations Contact - 31/12/09
Corporate Officer/Principal - -
Comptroller/Controller/Auditor - 31/12/00
Corporate Secretary 56 30/12/14

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 56 31/12/05
Director/Board Member - 30/12/14
Director/Board Member - 30/12/14
Director/Board Member 70 22/07/20
Director/Board Member - 30/12/14
Chairman - 30/12/14
Director/Board Member - 06/11/17
Director/Board Member - 30/12/14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 80,920,395 15,878,657 ( 19.62 %) 836,927 ( 1.034 %) 19.62 %

Shareholders

NameEquities%Valuation
Reig Jofre Investments SL
61.79 %
49,210,192 61.79 % 131 M PTS
7,881,473 9.897 % 21 M PTS
4,807,306 6.037 % 13 M PTS
Quaero Capital SA
3.005 %
2,393,424 3.005 % 6 M PTS
832,832 1.046 % 2 M PTS
Caixabank Asset Management SGIIC SA
0.5286 %
420,919 0.5286 % 1 M PTS
Solventis SGIIC SA
0.4394 %
349,930 0.4394 % 931 664 PTS
Andbank Wealth Management SGIIC SAU
0.2828 %
225,195 0.2828 % 599 566 PTS
Quadriga Asset Managers SGIIC SA
0.1946 %
155,000 0.1946 % 412 677 PTS
GVC Gaesco Gestión SGIIC SA
0.1746 %
139,006 0.1746 % 370 094 PTS

Holdings

NameEquities%Valuation
832,832 1.05% 2,217,357 $

Company contact information

Laboratorio Reig Jofre SA

Gran Capita, 10 Sant Joan Despi

08970, Barcelona

+34 93 480 67 10

http://www.reigjofre.com
address Laboratorio Reig Jofre SA(0RB1)
  1. Stock Market
  2. Equities
  3. RJF Stock
  4. 0RB1 Stock
  5. Company Laboratorio Reig Jofre SA